Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

2.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

3.

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

4.

Experts suggest Michelangelo depicted breast cancer in the Sistine Chapel fresco

5.

Food insecurity linked to tumor growth in pediatric neuroblastoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot